Cargando…
KDM3A, a Novel Blood-Based Biomarker in Colorectal Carcinogenesis
Colorectal cancer (CRC) is one of the leading causes of cancer-linked deaths globally. The determination of biomarkers is important in the prognosis and treatment of CRC. Previous studies emphasized the relationship between hypoxia and CRC in humans, and there is strong evidence that this process is...
Autores principales: | Polat, D., Onur, E., Yılmaz, N., Sökücü, M., Gerçeker, O.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230839/ https://www.ncbi.nlm.nih.gov/pubmed/37265967 http://dx.doi.org/10.2478/bjmg-2022-0021 |
Ejemplares similares
-
KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis
por: Wu, Meng-Chen, et al.
Publicado: (2019) -
Tip60‐dependent acetylation of KDM2B promotes osteosarcoma carcinogenesis
por: Shi, Xin, et al.
Publicado: (2019) -
KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression
por: Liu, Fen, et al.
Publicado: (2022) -
KDM3A and KDM3B Maintain Naïve Pluripotency Through the Regulation of Alternative Splicing
por: Dillingham, Caleb, et al.
Publicado: (2023) -
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR
por: D’Amore, Claudio, et al.
Publicado: (2022)